SPY334.89+2.52 0.76%
DIA277.50+3.08 1.12%
IXIC11,167.51+82.26 0.74%

Benchmark Maintains Speculative Buy on cbdMD, Lowers Price Target to $7

Benchmark maintains cbdMD (AMEX:YCBD) with a Speculative Buy and lowers the price target from $9 to $7.

Benzinga · 12/19/2019 12:45

Benchmark maintains cbdMD (AMEX:YCBD) with a Speculative Buy and lowers the price target from $9 to $7.